Health Technology · Pharmaceuticals: Other · NSE: SUDEEPPHRM · data 2026-10-09
Sudeep Pharma Limited
Health check: Strong (7/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹1,050.3
Market cap
₹12,559 cr
P/E
65
P/B
—
ROE
25.1%
ROCE
28.4%
Debt / equity
0.17
Dividend yield
0.13%
1-year return
43.9%
52-week high
₹1,378
52-week low
₹524.05
Operating margin
32.2%
Growth
| Revenue (last 12 months) | ₹676 cr |
| Net profit (last 12 months) | ₹183 cr |
| Sales growth, 3 years (yearly) | 14.4% |
| Profit growth, 3 years (yearly) | 40.5% |
Similar companies
Cipla Ltd (CIPLA) · Aurobindo Pharma Ltd (AUROPHARMA) · Lupin Limited (LUPIN) · Granules India Limited (GRANULES) · Amrutanjan Health Care Limited (AMRUTANJAN)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open SUDEEPPHRM in NSE Scanner →